By Dr Jia (Jenny) Liu

Conference Papers

Liu J; Bui KT; Serafimovska A; Kialy BE; Hui MN; Goodwin A; McNeil CM; Costa DSJ; Butow P; Beith JM, 2020, 'CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020

Conference Presentations

Peng J; Liu JJ; Daniels B; Firriolo J; Laaksonen MA; Hawkins NJ; Meagher AP; Hayes I; Croxford M; Cai S; Ward RL, 2014, 'RETROSPECTIVE COMPARISON OF RECTAL CANCER TREATMENT IN CHINA AND AUSTRALIA FROM 1995-2012', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Hall A; Crumbaker M; Pham J; Liu JJ; Sim H-W; Joshua AM, 2024, 'A meta-analysis of overall survival and response in metastatic adrenocortical carcinoma: A review of 23 prospective trials of 880 patients.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 42, pp. 4 - 4, presented at American-Society-of-Clinical-Oncology: Genitourinary Cancers Symposium (ASCO GU), CA, San Francisco, 25 January 2024 - 27 January 2024, http://dx.doi.org/10.1200/JCO.2024.42.4_suppl.4

Hurwitz J; Nindra U; Liu J, 2022, 'Systematic review of neoadjuvant and definitive immunotherapy in head and neck squamous cell carcinoma', in Asia-Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 38 - 38, presented at Medical Oncology Group of Australia Incorporated Annual Scientific Meeting 2022, https://doi.org/10.1111/ajco.13856

Zdanska O; Zdansky P; Liu J; Joshua A; Stanners M; Rogers C, 2022, 'Patient experiences of prolonged living with cancer during early phase trial treatment', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 147 - 147

Parmar J; Aggarwal N; Zdanska O; Yousif J; Hurwitz J; Handel E; Rodrigues A; Prawira A; Joshua A; Cosman R; Liu J, 2022, 'Telehealth maintains access to early phase clinical trials during the Covid-19 pandemic', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 154 - 155

Liu JJ; Zhang M; Rose B; Veillard A-S; Jones D; Lee S; Hong A, 2014, 'KI67 EXPRESSION HAS PROGNOSTIC SIGNIFICANCE IN RELATION TO HUMAN PAPILLOMAVIRUS STATUS IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 10, pp. 180 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900317&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu J; Hesson LB; Meagher AP; Bourke MJ; Hawkins NJ; Rand KN; Molloy PL; Pimanda JE; Ward RL, 2012, 'Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-3125

Other

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.c.7761697

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051228

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051225

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051222

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051219

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051216

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051213

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051210

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051207

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051204

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760596

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760593

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760590

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760587

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760584

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760581

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760578

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760575

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760572

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760569

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760566

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760563

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760560

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760557

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Table 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760554

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Table 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760551

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760548

Back to profile page